Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Published in: European Journal of Nuclear Medicine and Molecular Imaging 8/2018

01-07-2018 | Original Article

18F-FDG PET in drug-resistant epilepsy due to focal cortical dysplasia type 2: additional value of electroclinical data and coregistration with MRI

Authors: Serge Desarnaud, Charles Mellerio, Franck Semah, Agathe Laurent, Elisabeth Landre, Bertrand Devaux, Catherine Chiron, Vincent Lebon, Francine Chassoux

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 8/2018

Login to get access

Abstract

Purpose

To assess the localizing value of 18F-FDG PET in patients operated on for drug-resistant epilepsy due to focal cortical dysplasia type 2 (FCD2).

Methods

We analysed 18F-FDG PET scans from 103 consecutive patients (52 males, 7–65 years old) with histologically proven FCD2. PET and MRI data were first reviewed by visual analysis blinded to clinical information and FCD2 location. The additional value of electroclinical data and PET/MRI coregistration was assessed by comparison with pathological results and surgical outcomes.

Results

Visual analysis of PET scans showed focal or regional hypometabolism corresponding to the FCD2 in 45 patients (44%), but the findings were doubtful or misleading in 37 patients and negative in 21. When considering electroclinical data, positive localization was obtained in 73 patients, and this increased to 85 (83%) after coregistration of PET and MRI data. Under the same conditions, MRI was positive in 61 patients (59%), doubtful in 15 and negative in 27. The additional value of PET was predominant in patients negative or doubtful on MRI, localizing the FCD2 in 35 patients (83%). Interobserver agreement correlated with the grade of hypometabolism: it was good in patients with mild to severe hypometabolism (82–95%), but moderate in those with subtle/doubtful hypometabolism (45%). The main factors influencing positive PET localization were the grade of hypometabolism and the size of the FCD2 (P < 0.0001). Misleading location (nine patients) was associated with a small FCD2 in the mesial frontal and central regions. Following limited cortical resection mainly located in extratemporal areas (mean follow-up 5.6 years), a seizure-free outcome was achieved in 94% of patients, including Engel’s class IA in 72%.

Conclusion

In this series, 18F-FDG PET contributed to the localization of FCD2 in 83% of patients. This high localizing value was obtained by integration of electroclinical data and PET/MRI coregistration. This approach may help improve the surgical outcome in extratemporal epilepsy, even in patients negative on MRI.
Literature
1.
Blumcke I, Spreafico R, Haaker G, Coras R, Kobow K, Bien CG, et al. Histopathological findings in brain tissue obtained during epilepsy surgery. N Engl J Med. 2017;377:1648–56.CrossRefPubMed
2.
Ryvlin P, Cross JH, Rheims S. Epilepsy surgery in children and adults. Lancet Neurol. 2014;13:1114–26.CrossRefPubMed
3.
Guerrini R, Duchowny M, Jayakar P, Krsek P, Kahane P, Tassi L, et al. Diagnostic methods and treatment options for focal cortical dysplasia. Epilepsia. 2015;56:1669–86.CrossRefPubMed
4.
Chassoux F, Rodrigo S, Semah F, Beuvon F, Landré E, Devaux B, et al. FDG-PET improves surgical outcome in negative-MRI Taylor type focal cortical dysplasias. Neurology. 2010;75:2168–75.CrossRefPubMed
5.
Rubí S, Setoain X, Donaire A, Bargalló N, Sanmartí F, Carreño M, et al. Validation of FDG-PET/MRI coregistration in nonlesional refractory childhood epilepsy. Epilepsia. 2011;52:2216–24.CrossRefPubMed
6.
Chassoux F, Landre E, Mellerio C, Turak B, Mann MW, Daumas-Duport C, et al. Type II focal cortical dysplasia: electro-clinical phenotypes and surgical outcome related to imaging. Epilepsia. 2012;53:349–58.CrossRefPubMed
7.
Blümcke I, Thom M, Aronica E, Armstrong DD, Vinters HV, Palmini A, et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia. 2011;52:158–74.CrossRefPubMed
8.
Engel J Jr, Van Ness PC, Rasmussen TB, Ojemann LM. Outcome with respect to epileptic seizures. In: Engel J Jr, editor. Surgical treatment of the epilepsies. 2nd ed. New York: Raven; 1993. p. 609–21.
9.
Mellerio C, Labeyrie MA, Chassoux F, Daumas-Duport C, Landre E, Turak B, et al. Optimizing MR imaging detection of type 2 focal cortical dysplasia: best criteria for clinical practice. AJNR Am J Neuroradiol. 2012;33:1932–8.CrossRefPubMed
10.
Rivière D, Geffroy D, Denghien I, Souedet N, Cointepas Y. BrainVISA: an extensible software environment for sharing multimodal neuroimaging data and processing tools. In: Proceedings of the 15th Annual Meeting of the Organization for Human Brain Mapping, 18–23 June 2009, San Francisco, California. http://​brainvisa.​info.
11.
Chassoux F, Devaux B, Landre E, Turak B, Nataf F, Varlet P, et al. Stereo-electroencephalography in focal cortical dysplasia: a 3D approach to delineating the dysplastic cortex. Brain. 2000;123:1733–51.CrossRefPubMed
12.
Lee SK, Choe G, Hong KS, Nam HW, Kim JY, Chung CK, et al. Neuroimaging findings of cortical dyslamination with cytomegaly. Epilepsia. 2001;42:850–6.CrossRefPubMed
13.
Kim YK, Lee DS, Lee SK, Chung CK, Chung JK, Lee MC. (18)F-FDG PET in localization of frontal lobe epilepsy: comparison of visual and SPM analysis. J Nucl Med. 2002;43:1167–74.PubMed
14.
Knowlton RC, Elgavish RA, Bartolucci A, Ojha B, Limdi N, Blount J, et al. Functional imaging: II. Prediction of epilepsy surgery outcome. Ann Neurol. 2008;64:35–41.CrossRefPubMed
15.
Salamon N, Kung J, Shaw SJ, Koo J, Koh S, Wu JY, et al. FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy. Neurology. 2008;71:1594–601.CrossRefPubMedPubMedCentral
16.
Paldino MJ, Yang E, Jones JY, Mahmood N, Sher A, Zhang W. Comparison of the diagnostic accuracy of PET/MRI to PET/CT-acquired FDG brain exams for seizure focus detection: a prospective study. Pediatr Radiol. 2017;47:1500–7.CrossRefPubMed
17.
Urbach H, Scheffler B, Heinrichsmeier T, von Oertzen J, Kral T, Wellmer J, et al. Focal cortical dysplasia of Taylor's balloon cell type: a clinicopathological entity with characteristic neuroimaging and histopathological features, and favorable postsurgical outcome. Epilepsia. 2002;43:33–40.CrossRefPubMed
18.
Besson P, Andermann F, Dubeau F, Bernasconi A. Small focal cortical dysplasia lesions are located at the bottom of a deep sulcus. Brain. 2008;13:3246–55.CrossRef
19.
Wagner J, Weber B, Urbach H, Elger CE, Huppertz HJ. Morphometric MRI analysis improves detection of focal cortical dysplasia type II. Brain. 2011;134:2844–54.CrossRefPubMed
20.
Mellerio C, Labeyrie MA, Chassoux F, Roca P, Alami O, Plat M, et al. 3T MRI improves the detection of transmantle sign in type 2 focal cortical dysplasia. Epilepsia. 2014;55:117–22.CrossRefPubMed
21.
Hong SJ, Kim H, Schrader D, Bernasconi N, Bernhardt BC, Bernasconi A. Automated detection of cortical dysplasia type II in MRI-negative epilepsy. Neurology. 2014;83:48–55.CrossRefPubMedPubMedCentral
22.
Mellerio C, Roca P, Chassoux F, Danière F, Cachia A, Lion S, et al. The power button sign: a newly described central sulcal pattern on surface rendering MR images of type 2 focal cortical dysplasia. Radiology. 2015;274:500–7.CrossRefPubMed
23.
Roca P, Mellerio C, Chassoux F, Rivière D, Cachia A, Charron S, et al. Sulcus-based MR analysis of focal cortical dysplasia located in the central region. PLoS One. 2015;10:e0122252.CrossRefPubMedPubMedCentral
24.
Colombo N, Tassi L, Deleo F, Citterio A, Bramerio M, Mai R, et al. Focal cortical dysplasia type IIa and IIb: MRI aspects in 118 cases proven by histopathology. Neuroradiology. 2012;54:1065–77.CrossRefPubMed
25.
Chassoux F, Navarro V, Catenoix H, Valton L, Vignal JP. Planning and management of SEEG. Neurophysiol Clin. 2018;48:25–37.CrossRefPubMed
26.
Rathore C, Dickson JC, Teotónio R, Ell P, Duncan JS. The utility of 18F-fluorodeoxyglucose PET (FDG PET) in epilepsy surgery. Epilepsy Res. 2014;108:1306–14.CrossRefPubMed
27.
Rubinger L, Chan C, D'Arco F, Moineddin R, Muthaffar O, Rutka JT, et al. Change in presurgical diagnostic imaging evaluation affects subsequent pediatric epilepsy surgery outcome. Epilepsia. 2016;57:32–40.CrossRefPubMed
28.
Lee SK, Lee SY, Kim KK, Hong KS, Lee DS, Chung CK. Surgical outcome and prognostic factors of cryptogenic neocortical epilepsy. Ann Neurol. 2005;58:525–32.CrossRefPubMed
29.
Chapman K, Wyllie E, Najm I, Ruggieri P, Bingaman W, Lüders J, et al. Seizure outcome after epilepsy surgery in patients with normal preoperative MRI. J Neurol Neurosurg Psychiatry. 2005;76:710–3.CrossRefPubMedPubMedCentral
30.
Krsek P, Maton B, Jayakar P, Dean P, Korman B, Rey G, et al. Incomplete resection of focal cortical dysplasia is the main predictor of poor postsurgical outcome. Neurology. 2009;72:217–23.CrossRefPubMed
31.
Widdess-Walsh P, Jeha L, Nair D, Kotagal P, Bingaman W, Najm I. Subdural electrode analysis in focal cortical dysplasia: predictors of surgical outcome. Neurology. 2007;69:660–7.CrossRefPubMed
32.
Tassi L, Colombo N, Garbelli R, Francione S, Lo Russo G, Mai R, et al. Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain. 2002;125:1719–32.CrossRefPubMed
33.
Fauser S, Schulze-Bonhage A, Honegger J, Carmona H, Huppertz HJ, Pantazis G, et al. Focal cortical dysplasias: surgical outcome in 67 patients in relation to histological subtypes and dual pathology. Brain. 2004;127:2406–18.CrossRefPubMed
34.
Kim DW, Lee SK, Chu K, Park KI, Lee SY, Lee CH, et al. Predictors of surgical outcome and pathologic considerations in focal cortical dysplasia. Neurology. 2009;72:211–6.CrossRefPubMed
35.
Harvey AS, Mandelstam SA, Maixner WJ, Leventer RJ, Semmelroch M, MacGregor D, et al. The surgically remediable syndrome of epilepsy associated with bottom-of-sulcus dysplasia. Neurology. 2015;84:2021–8.CrossRefPubMedPubMedCentral
36.
Archambaud F, Bouilleret V, Hertz-Pannier L, Chaumet-Riffaud P, Rodrigo S, Dulac O, et al. Optimizing statistical parametric mapping analysis of 18F-FDG PET in children. EJNMMI Res. 2013;3:2.CrossRefPubMedPubMedCentral
37.
Mendes Coelho VC, Morita ME, Amorim BJ, Ramos CD, Yasuda CL, Tedeschi H, et al. Automated online quantification method for 18F-FDG positron emission tomography/CT improves detection of the epileptogenic zone in patients with pharmacoresistant epilepsy. Front Neurol. 2017;8:453.CrossRefPubMedPubMedCentral
38.
Mayoral M, Marti-Fuster B, Carreño M, Carrasco JL, Bargalló N, Donaire A, et al. Seizure-onset zone localization by statistical parametric mapping in visually normal (18)F-FDG-PET studies. Epilepsia. 2016;57:1236–44.CrossRefPubMed
39.
Tan YL, Kim H, Lee S, Tihan T, Ver Hoef L, Mueller SG, et al. Quantitative surface analysis of combined MRI and PET enhances detection of focal cortical dysplasias. Neuroimage. 2018;166:10–8.CrossRefPubMed
40.
van't Klooster MA, Huiskamp G, Zijlmans M, Debets RM, Comans EF, Bouvard S, et al. Can we increase the yield of FDG-PET in the preoperative work-up for epilepsy surgery? Epilepsy Res. 2014;108:1095–105.CrossRef
Metadata
Title
18F-FDG PET in drug-resistant epilepsy due to focal cortical dysplasia type 2: additional value of electroclinical data and coregistration with MRI
Authors
Serge Desarnaud
Charles Mellerio
Franck Semah
Agathe Laurent
Elisabeth Landre
Bertrand Devaux
Catherine Chiron
Vincent Lebon
Francine Chassoux
Publication date
01-07-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 8/2018
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-018-3994-3

Other articles of this Issue 8/2018

European Journal of Nuclear Medicine and Molecular Imaging 8/2018 Go to the issue

Editorial Commentary

Alphatherapy, the new impetus to targeted radionuclide therapy?

Original Article

Amyloid load but not regional glucose metabolism predicts conversion to Alzheimer’s dementia in a memory clinic population

Original Article

Preoperative [18F]FDG PET/CT tumour heterogeneity index in patients with uterine leiomyosarcoma: a multicentre retrospective study

Original Article

Clinical utility of simultaneous whole-body 18F-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma

Original Article

Dual-time point 18F-FDG PET/CT for the staging of oesophageal cancer: the best diagnostic performance by retention index for N-staging in non-calcified lymph nodes

Original Article

The central zone has increased 68Ga-PSMA-11 uptake: “Mickey Mouse ears” can be hot on 68Ga-PSMA-11 PET